Lorenzi, Alice R <br/><br/>
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.  [electronic resource] 

 -  Arthritis and rheumatism  Feb 2008 
 - 370-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.23122  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alemtuzumab<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infections--mortality<br/>Kaplan-Meier Estimate<br/>Lymphocyte Subsets--drug effects<br/>Lymphopenia--chemically induced<br/>Male<br/>Medical Records<br/>Middle Aged<br/>Morbidity<br/>Neoplasms--mortality<br/>Time Factors<br/>Treatment Outcome